Home › NDC Lookup › RxCUI directory › RxCUI 992536

Terbinafine hydrochloride 10 MG/ML Topical Spray [Lamisil] — RxCUI 992536

RxNorm drug concept · Semantic branded drug
RxCUI 992536 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI992536
Official nameTerbinafine hydrochloride 10 MG/ML Topical Spray [Lamisil]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLamisil 1 % Topical Spray; LamISIL AT 1 % Topical Spray; Lamisil 10 MG/ML Topical Spray
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Terbinafine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the form. The tablets treat fungal infections of the toenails or fingernails. Topical products like Lamisil AT treat athlete’s foot, jock itch and ringworm. Your doct...
  • You take one tablet by mouth once a day, with or without food. Fingernails take a shorter course than toenails. Your nail can look better only after healthy nail grows out, which t...
  • Liver failure has happened with terbinafine tablets, even in people with no liver problems. A blood test before and during treatment helps catch trouble early. Call your doctor rig...
  • Headache, diarrhea, rash, upset stomach and itching are the common ones, and they are usually mild. Call your doctor for taste or smell changes, low mood, blistering or spreading r...
📖 Read our full Terbinafine guide →

🕸️ Concept Web — How Terbinafine hydrochloride 10 MG/ML Topical Spray... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Terbinafine hydrochloride 10 MG/ML Topical Spray [Lamisil] RxCUI 992536

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Terbinafine 37801
    • Terbinafine hydrochloride 235838
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lamisil 217956
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Terbinafine Topical Spray 385102
    • Terbinafine hydrochloride Topical Spray 2648958
    • Terbinafine Topical Product 1161497
    • Terbinafine hydrochloride Topical Product 2662078
    • Terbinafine Topical Spray [Lamisil] 544606
    • Terbinafine hydrochloride Topical Spray [Lamisil] 2654518
    • Lamisil Topical Product 1174991
    • Topical Spray 346165
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Terbinafine hydrochloride 10 MG/ML Topical Spray SCD · 992535
  • Terbinafine hydrochloride 10 MG/ML SCDC · 992527
  • Terbinafine Topical Spray SCDF · 385102
  • Terbinafine hydrochloride Topical Spray SCDFP · 2648958
  • Terbinafine Topical Product SCDG · 1161497
  • Terbinafine hydrochloride Topical Product SCDGP · 2662078

Brand-Name Concepts

  • Terbinafine hydrochloride 10 MG/ML [Lamisil] SBDC · 992529
  • Terbinafine Topical Spray [Lamisil] SBDF · 544606
  • Terbinafine hydrochloride Topical Spray [Lamisil] SBDFP · 2654518
  • Lamisil Topical Product SBDG · 1174991
  • Lamisil BN · 217956

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 992536 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
84485-3605-04 120 g in 1 CAN (84485-3605-4) Lamisil AT Karo Healthcare Inc. 2025-12-10
84485-3606-04 120 g in 1 CAN (84485-3606-4) Lamisil AT Karo Healthcare Inc. 2025-12-10
Observed labelers: Karo Healthcare Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.